Janux Therapeutics Inc
JANX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$695.66M
Close$
$-3.81
133.5% downside
Current Fair Value
133.5% downsideOvervalued by 133.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $695.66 Million |
|---|---|
| Enterprise Value | $701.44 Million |
| Earnings per Share | $-1.83 |
| Beta | 2.39 |
| Outstanding Shares | 63,089,950 |
Return
| Return on Equity | -15.78% |
|---|---|
| Return on Assets | -14.63% |
| Return on Invested Capital | -16.54% |
Valuation & Multiples
| P/E Ratio | -7.11 |
|---|---|
| PEG | 62.99 |
| Price to Sales | - |
| Price to Book Ratio | 0.81 |
| Enterprise Value to Revenue | 22.5 |
| Enterprise Value to EBIT | -4.56 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 10, 2026
EPS Estimate
-$0.49
Consensus analyst estimateRevenue Estimate
$6.70 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
-$0.52
Consensus analyst estimateRevenue Estimate
$4.00 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 71.22% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.19%▼ 91.98% |
|---|---|
| Total Invested | $56.38M▼ 94.00% |
| Investors Holding | 67▼ 138.00% |
About Janux Therapeutics Inc
16 employees
